Cargando…
Improved Antiproliferative Activity and Fluorescence of a Dinuclear Gold(I) Bisimidazolylidene Complex via Anthracene‐Modification
A straightforward modification route to obtain mono‐ and di‐substituted anthroyl ester bridge functionalized dinuclear Au(I) bis‐N‐heterocyclic carbene complexes is presented. The functionalization can be achieved starting from a hydroxyl‐functionalized ligand precursor followed by transmetallation...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756789/ https://www.ncbi.nlm.nih.gov/pubmed/33405335 http://dx.doi.org/10.1002/asia.202001104 |
_version_ | 1783626618190692352 |
---|---|
author | Jakob, Christian H. G. Dominelli, Bruno Schlagintweit, Jonas F. Fischer, Pauline J. Schuderer, Franziska Reich, Robert M. Marques, Fernanda Correia, João D. G. Kühn, Fritz E. |
author_facet | Jakob, Christian H. G. Dominelli, Bruno Schlagintweit, Jonas F. Fischer, Pauline J. Schuderer, Franziska Reich, Robert M. Marques, Fernanda Correia, João D. G. Kühn, Fritz E. |
author_sort | Jakob, Christian H. G. |
collection | PubMed |
description | A straightforward modification route to obtain mono‐ and di‐substituted anthroyl ester bridge functionalized dinuclear Au(I) bis‐N‐heterocyclic carbene complexes is presented. The functionalization can be achieved starting from a hydroxyl‐functionalized ligand precursor followed by transmetallation of the corresponding Ag complex or via esterification of the hydroxyl‐functionalized gold complex. The compounds are characterized by NMR‐spectroscopy, ESI‐MS, elemental analysis and SC‐XRD. The mono‐ester Au complex shows quantum yields around 18%. In contrast, the corresponding syn‐di‐ester Au complex, exhibits significantly lower quantum yields of around 8%. Due to insufficient water solubility of the di‐ester, only the mono‐ester complex has been tested regarding its antiproliferative activity against HeLa‐ (cervix) and MCF‐7‐ (breast) cancer cell lines and a healthy fibroblast cell line (V79). IC(50) values of 7.26 μM in the HeLa cell line and 7.92 μM in the MCF‐7 cell line along with selectivity indices of 8.8 (HeLa) and 8.0 (MCF‐7) are obtained. These selectivity indices are significantly higher than those obtained for the reference drugs cisplatin or auranofin. |
format | Online Article Text |
id | pubmed-7756789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77567892020-12-28 Improved Antiproliferative Activity and Fluorescence of a Dinuclear Gold(I) Bisimidazolylidene Complex via Anthracene‐Modification Jakob, Christian H. G. Dominelli, Bruno Schlagintweit, Jonas F. Fischer, Pauline J. Schuderer, Franziska Reich, Robert M. Marques, Fernanda Correia, João D. G. Kühn, Fritz E. Chem Asian J Communications A straightforward modification route to obtain mono‐ and di‐substituted anthroyl ester bridge functionalized dinuclear Au(I) bis‐N‐heterocyclic carbene complexes is presented. The functionalization can be achieved starting from a hydroxyl‐functionalized ligand precursor followed by transmetallation of the corresponding Ag complex or via esterification of the hydroxyl‐functionalized gold complex. The compounds are characterized by NMR‐spectroscopy, ESI‐MS, elemental analysis and SC‐XRD. The mono‐ester Au complex shows quantum yields around 18%. In contrast, the corresponding syn‐di‐ester Au complex, exhibits significantly lower quantum yields of around 8%. Due to insufficient water solubility of the di‐ester, only the mono‐ester complex has been tested regarding its antiproliferative activity against HeLa‐ (cervix) and MCF‐7‐ (breast) cancer cell lines and a healthy fibroblast cell line (V79). IC(50) values of 7.26 μM in the HeLa cell line and 7.92 μM in the MCF‐7 cell line along with selectivity indices of 8.8 (HeLa) and 8.0 (MCF‐7) are obtained. These selectivity indices are significantly higher than those obtained for the reference drugs cisplatin or auranofin. John Wiley and Sons Inc. 2020-10-30 2020-12-14 /pmc/articles/PMC7756789/ /pubmed/33405335 http://dx.doi.org/10.1002/asia.202001104 Text en © 2020 The Authors. Chemistry – An Asian Journal published by Wiley-VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Communications Jakob, Christian H. G. Dominelli, Bruno Schlagintweit, Jonas F. Fischer, Pauline J. Schuderer, Franziska Reich, Robert M. Marques, Fernanda Correia, João D. G. Kühn, Fritz E. Improved Antiproliferative Activity and Fluorescence of a Dinuclear Gold(I) Bisimidazolylidene Complex via Anthracene‐Modification |
title | Improved Antiproliferative Activity and Fluorescence of a Dinuclear Gold(I) Bisimidazolylidene Complex via Anthracene‐Modification |
title_full | Improved Antiproliferative Activity and Fluorescence of a Dinuclear Gold(I) Bisimidazolylidene Complex via Anthracene‐Modification |
title_fullStr | Improved Antiproliferative Activity and Fluorescence of a Dinuclear Gold(I) Bisimidazolylidene Complex via Anthracene‐Modification |
title_full_unstemmed | Improved Antiproliferative Activity and Fluorescence of a Dinuclear Gold(I) Bisimidazolylidene Complex via Anthracene‐Modification |
title_short | Improved Antiproliferative Activity and Fluorescence of a Dinuclear Gold(I) Bisimidazolylidene Complex via Anthracene‐Modification |
title_sort | improved antiproliferative activity and fluorescence of a dinuclear gold(i) bisimidazolylidene complex via anthracene‐modification |
topic | Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756789/ https://www.ncbi.nlm.nih.gov/pubmed/33405335 http://dx.doi.org/10.1002/asia.202001104 |
work_keys_str_mv | AT jakobchristianhg improvedantiproliferativeactivityandfluorescenceofadinucleargoldibisimidazolylidenecomplexviaanthracenemodification AT dominellibruno improvedantiproliferativeactivityandfluorescenceofadinucleargoldibisimidazolylidenecomplexviaanthracenemodification AT schlagintweitjonasf improvedantiproliferativeactivityandfluorescenceofadinucleargoldibisimidazolylidenecomplexviaanthracenemodification AT fischerpaulinej improvedantiproliferativeactivityandfluorescenceofadinucleargoldibisimidazolylidenecomplexviaanthracenemodification AT schudererfranziska improvedantiproliferativeactivityandfluorescenceofadinucleargoldibisimidazolylidenecomplexviaanthracenemodification AT reichrobertm improvedantiproliferativeactivityandfluorescenceofadinucleargoldibisimidazolylidenecomplexviaanthracenemodification AT marquesfernanda improvedantiproliferativeactivityandfluorescenceofadinucleargoldibisimidazolylidenecomplexviaanthracenemodification AT correiajoaodg improvedantiproliferativeactivityandfluorescenceofadinucleargoldibisimidazolylidenecomplexviaanthracenemodification AT kuhnfritze improvedantiproliferativeactivityandfluorescenceofadinucleargoldibisimidazolylidenecomplexviaanthracenemodification |